| Uremic Serum and Ubiquitylation of Tissue Factor. | |
| | |
MedLine Citation:
|
PMID: 23269490 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Stent thrombosis is a major clinical problem associated with a high rate of mortality.(1,2) The development of drug-eluting stents (DES) has significantly reduced restenosis compared with bare metal stents (BMS) due to the antiproliferative agents inhibiting vascular smooth muscle (VSMC) proliferation. However, the rate of stent thrombosis associated with DES continues to be a major concern with rates between 0.3 and 1.1% within 3 years.(1) Thrombosis is likely in part due to the fact that the antiproliferative drugs also inhibit re-endothelization of the vessel. Furthermore, patients with chronic renal failure have worse outcomes after stenting and have as much as an 8 fold increase in 1-year cardiac mortality following coronary intervention.(3). |
| | |
Authors:
|
Nigel Mackman |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-12-25 |
Journal Detail:
|
Title: Circulation Volume: - ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
University of North Carolina at Chapel Hill, Chapel Hill, NC. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Uremic Serum and Solutes Increases Post Vascular Interventional Thrombotic Risk through Altered Stab...
Next Document: Mycobacterial and mouse HSP70 have immuno-modulatory effects on dendritic cells.